The legacy success of sildenafil has undeniably shaped the drug landscape. However, putting money in companies heavily focused on biosimilars and the waning patent rights surrounding this blockbuster https://nowbookmarks.com/story21433071/sildenafil-and-pharmaceutical-companies-a-risky-investment